“celgene” Archives

in
Entry Author Date Location
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More 09/16/16 National
Celgene Touts Data From Early Study of Oral GI Drug 09/12/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug 09/07/16 Boston
Pfizer Shells Out $14B to Win Medivation Sweepstakes 08/22/16 San Francisco
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup 08/11/16 Boston
Cleave Biosciences Receives $37,000,000 Series B Financing 08/09/16 San Francisco
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV 08/02/16 Boston
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Oncorus Lands $57,000,000 Series A Financing Round 07/20/16 Boston
Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses 07/19/16 Boston
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Q2 VC Funding Soars in San Diego (After Revisions), and Top 10 Deals 07/18/16 San Diego
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More 06/24/16 National
Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case 06/22/16 Boston
Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases 06/22/16 Boston
Epizyme Touts Early Data From Key Trial Of Blood Cancer Drug 06/19/16 Boston
Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another 06/11/16 Boston
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
Agenovir Gets $10.6M To Take on Viral Infections With CRISPR 05/18/16 San Francisco
Agenovir Lands $10,600,000 Series A Financing Round 05/18/16 San Francisco
Agios, Celgene Jump into Immuno-Oncology in Revamped Alliance 05/17/16 Boston
Page 1 of 12 next page »